Expanding Access to Naloxone

Using an older browser? Can't see the video above? You'll need to download the MP3 file instead.

You will be listening to one of our many editorial discussions. This one took place on May 14, 2018 and is led by our Editor, Sherri Boehringer, PharmD. You’ll hear the voice of Editorial Board member Reid B. Blackwelder, MD, FAAFP, East Tennessee State University. You’ll also listen to an expert in naloxone use and overdose education, Jeffrey Bratberg, PharmD, University of Rhode Island, Providence; and addiction specialist and opioid overdose expert Sharon Stancliff, MD, FASAM, Harm Reduction Coalition, New York. You can read our brief, to-the-point Recommendation and dive into the evidence-based details if you wish.

Get in on future discussions

The PL Voices audio snippet above is brief. It is taken from the full hour-long session we hold every month. We call these sessions PL Voices - Clinical Recommendations. You are invited to join any of them. Plus you can participate if you want, by asking questions or making suggestions during the discussion.

You also get CE credit for each full session. And if your state requires LIVE CE, these sessions meet that requirement. Your subscription needs to include PL CE Live for you to attend.

I am a PL CE Live subscriber. Register me so I can attend an upcoming session of PL Voices - Clinical Recommendations.

Add PL CE Live to my subscription, so that I can attend any future full session of PL Voices - Clinical Recommendations.

Related Articles